Literature DB >> 7972299

Acute behavioral effects of MK-801 in rhesus monkeys: assessment using an operant test battery.

E A Buffalo1, M P Gillam, R R Allen, M G Paule.   

Abstract

The acute effects of MK-801, a selective, noncompetitive NMDA receptor antagonist, were assessed using an operant test battery (OTB) of complex food-reinforced tasks that are thought to depend upon relatively specific brain functions such as motivation to work for food (progressive ratio, PR), learning (incremental repeated acquisition, IRA), color and position discrimination (conditioned position responding, CPR), time estimation (temporal response differentiation, TRD), and short-term memory and attention (delayed matching-to-sample, DMTS). Endpoints included response rates (RR), accuracies (ACC), and percent task completed (PTC). MK-801 (0.003-0.075 mg/kg, IV), given 15 min pretesting, produced significant dose-dependent decreases in measures of IRA and TRD performance at doses > or = 0.03 mg/kg. In both tasks, MK-801 produced significant decreases in accuracy at doses lower than those required to affect response rate. MK-801 also produced statistically significant decreases in PR, CPR, and DMTS measures, but only at higher doses (> or = 0.056 mg/kg) that caused significant decreases in both response rates and accuracies. These results indicate that, in monkeys, performance of operant tasks designed to model learning and time estimation is more sensitive to the disruptive effects of MK-801 than performance of tasks that model motivation, color, and position discrimination, and short-term memory and attention.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972299     DOI: 10.1016/0091-3057(94)90203-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  Morphine and MK-801 administration leads to alternative N-methyl-D-aspartate receptor 1 splicing and associated changes in reward seeking behavior and nociception on an operant orofacial assay.

Authors:  E M Anderson; A Y Del Valle-Pinero; S K Suckow; T A Nolan; J K Neubert; R M Caudle
Journal:  Neuroscience       Date:  2012-04-21       Impact factor: 3.590

Review 2.  Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia.

Authors:  Nurith Amitai; Athina Markou
Journal:  Biol Psychiatry       Date:  2010-05-21       Impact factor: 13.382

3.  Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys.

Authors:  Michael A Taffe; Michael R Weed; Tannia Gutierrez; Sophia A Davis; Lisa H Gold
Journal:  Psychopharmacology (Berl)       Date:  2002-01-22       Impact factor: 4.530

4.  Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.

Authors:  John G Csernansky; Maureen Martin; Renu Shah; Amy Bertchume; Jenny Colvin; Hongxin Dong
Journal:  Neuropsychopharmacology       Date:  2005-12       Impact factor: 7.853

5.  Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia.

Authors:  Ikwunga Wonodi; Robert P McMahon; Nithin Krishna; Braxton D Mitchell; Judy Liu; Matthew Glassman; L Elliot Hong; James M Gold
Journal:  Schizophr Res       Date:  2014-11-14       Impact factor: 4.939

6.  Ketamine impairs multiple cognitive domains in rhesus monkeys.

Authors:  Michael A Taffe; Sophia A Davis; Tannia Gutierrez; Lisa H Gold
Journal:  Drug Alcohol Depend       Date:  2002-10-01       Impact factor: 4.492

7.  Progressive ratio performance following challenge with antipsychotics, amphetamine, or NMDA antagonists in adult rats treated perinatally with phencyclidine.

Authors:  Jenny L Wiley; Amelia D Compton
Journal:  Psychopharmacology (Berl)       Date:  2004-07-08       Impact factor: 4.530

8.  The role of mediodorsal thalamus in temporal differentiation of reward-guided actions.

Authors:  Chunxiu Yu; Jay Gupta; Henry H Yin
Journal:  Front Integr Neurosci       Date:  2010-05-21

9.  NMDA receptor function, memory, and brain aging.

Authors:  J W Newcomer; N B Farber; J W Olney
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

10.  Sensorimotor gating impairments induced by MK-801 treatment may be reduced by tolerance effect and by familiarization in monkeys.

Authors:  Patricia G Saletti; Rafael S Maior; Etsuro Hori; Hisao Nishijo; Carlos Tomaz
Journal:  Front Pharmacol       Date:  2015-09-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.